{
    "2019-07-08": [
        [
            {
                "time": "",
                "original_text": "股获券商买入评级，埃斯顿目标涨幅达53.86%",
                "features": {
                    "keywords": [
                        "券商",
                        "买入评级",
                        "埃斯顿",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "机械制造",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康泰生物:19H1业绩符合市场预期，预计下半年业绩持续改善",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "19H1业绩",
                        "市场预期",
                        "下半年业绩",
                        "持续改善"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}